Owner only: item control page
New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Hafner, Christian, Reichle, Albrecht and Vogt, Thomas (2005) New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy. Current Cancer Drug Targets 5 (6), pp. 393-419.Date of publication of this fulltext: 19 Dec 2024 14:58
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Current Cancer Drug Targets | ||||
| Publisher: | BENTHAM SCIENCE PUBL LTD | ||||
|---|---|---|---|---|---|
| Place of Publication: | SHARJAH | ||||
| Volume: | 5 | ||||
| Number of Issue or Book Chapter: | 6 | ||||
| Page Range: | pp. 393-419 | ||||
| Date | 2005 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Keywords | ACTIVATED-RECEPTOR-GAMMA; ENDOTHELIAL GROWTH-FACTOR; SELECTIVE CYCLOOXYGENASE-2 INHIBITOR; CELL-CYCLE ARREST; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN PROSTATE-CANCER; HUMAN HEPATOCELLULAR-CARCINOMA; HUMAN PANCREATIC-CANCER; METASTATIC BREAST-CANCER; FAMILIAL ADENOMATOUS POLYPOSIS; tumor-stroma interaction; stroma-targeted therapy; PPAR gamma; COX-2; mTOR; rapamycin; metronomic chemotherapy; tumor angiogenesis; antiangiogenic | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 70487 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric